Table 3:
1 week group | 2 week group | 4 week group | 4 week plusIPV group | Total | |
---|---|---|---|---|---|
| |||||
Mild to moderate adverse events | |||||
Burn injury | 0 | 0 | 0 | 1 | 1 |
Conjunctivitis | 0 | 0 | 2 | 1 | 3 |
Diarrhoea | 2 | 0 | 0 | 2 | 4 |
Vaccine-related fever | 1 | 0 | 0 | 2 | 3 |
Respiratory infection | 1 | 1 | 4 | 1 | 7 |
Oral candidiasis | 0 | 1 | 0 | 1 | 2 |
Skin infection | 1 | 0 | 2 | 1 | 4 |
Measles | 0 | 1 | 0 | 0 | 1 |
Varicella | 0 | 1 | 0 | 0 | 1 |
Serious adverse events | |||||
Pneumonia | 1 | 0 | 1 | 0 | 2 |
Total | 6 | 4 | 9 | 9 | 28 |
Data are n.